Amedeo Smart

Free Medical Literature Service

 

Amedeo

Bacterial Infections and Mycoses
  Free Subscription

Articles published in
Am J Respir Crit Care Med
    May 2023
  1. MITNICK CD, Nunn AJ
    Ascertainment Bias in TB Treatment Trials: Can Systematic Assessment of Objective Endpoints Solve It?
    Am J Respir Crit Care Med. 2023;207:1269-1270.
    >> Share

  2. KURBATOVA EV, Phillips PPJ, Dorman SE, Sizemore EE, et al
    A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.
    Am J Respir Crit Care Med. 2023;207:1376-1382.
    >> Share

  3. LIU Y, Xu J, Wang C, Lu B, et al
    Pulmonary Mucormycosis with Rib Involvement in an Immunocompromised Patient.
    Am J Respir Crit Care Med. 2023;207:1393-1394.
    >> Share

    April 2023
  4. BORGES DE ALMEIDA CP, Mitnick CD
    Intervening on Social Determinants for Better Outcomes in Pediatric Tuberculosis Management.
    Am J Respir Crit Care Med. 2023 Apr 19. doi: 10.1164/rccm.202303-0601.
    >> Share

  5. MARTINEZ L, Zar HJ
    Reply to: Intervening on Social Determinants for Better Outcomes in Pediatric Tuberculosis Management.
    Am J Respir Crit Care Med. 2023 Apr 19. doi: 10.1164/rccm.202304-0629.
    >> Share

  6. MASEKELA R, Mandalakas AM
    Pediatric Post-TB Lung Disease: Ready for Prime Time?
    Am J Respir Crit Care Med. 2023;207:975-977.
    >> Share

    February 2023
  7. TREVISI L, Hernan MA, Mitnick CD, Khan U, et al
    Effectiveness of Bedaquiline Use Beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
    Am J Respir Crit Care Med. 2023 Feb 21. doi: 10.1164/rccm.202211-2125.
    >> Share

  8. MARTINEZ L, Gray DM, Botha M, Nel M, et al
    The Long-Term Impact of Early-Life Tuberculosis Disease on Child Health: A Prospective Birth Cohort Study.
    Am J Respir Crit Care Med. 2023 Feb 6. doi: 10.1164/rccm.202208-1543.
    >> Share

    January 2023
  9. STAGG HR, Thompson JA, Lipman MCI, Sloan DJ, et al
    Forgiveness Is the Attribute of the Strong: Nonadherence and Regimen Shortening in Drug-sensitive Tuberculosis.
    Am J Respir Crit Care Med. 2023;207:193-205.
    >> Share

  10. VELASQUEZ GE, Nahid P
    Promise and Peril of Pretomanid-Rifamycin Regimens for Drug-Susceptible Tuberculosis.
    Am J Respir Crit Care Med. 2023 Jan 11. doi: 10.1164/rccm.202212-2262.
    >> Share

    December 2022
  11. DOOLEY KE, Hendricks B, Gupte N, Barnes G, et al
    Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results.
    Am J Respir Crit Care Med. 2022 Dec 1. doi: 10.1164/rccm.202208-1475.
    >> Share


  12. Erratum: Response to Hypoxia and the Ensuing Dysregulation of Inflammation Impacts Mycobacterium tuberculosis Pathogenicity.
    Am J Respir Crit Care Med. 2022;206:1434.
    >> Share

  13. HENRIQUES-NORMARK B, Narciso AR
    An Experimental Human Colonization Model with Pneumococcal Serotype 3 has the Potential to be Used for Vaccine Studies.
    Am J Respir Crit Care Med. 2022;206:1312-1314.
    >> Share

  14. ROBINSON RE, Mitsi E, Nikolaou E, Pojar S, et al
    Human Infection Challenge with Serotype 3 Pneumococcus.
    Am J Respir Crit Care Med. 2022;206:1379-1392.
    >> Share

    November 2022
  15. BEENTJES D, Shears RK, French N, Neill DR, et al
    Mechanistic Insights into the Impact of Air Pollution on Pneumococcal Pathogenesis and Transmission.
    Am J Respir Crit Care Med. 2022;206:1070-1080.
    >> Share

    October 2022
  16. CHECKLEY W
    Tuberculosis, Wildfires, and Case-Crossover Studies: An Epidemiological Trifecta?
    Am J Respir Crit Care Med. 2022 Oct 31. doi: 10.1164/rccm.202210-1936.
    >> Share

    September 2022

  17. Erratum: Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling.
    Am J Respir Crit Care Med. 2022;206:800-801.
    >> Share

  18. LINDE LR, Readhead A, Barry PM, Balmes JR, et al
    Tuberculosis Diagnoses Following Wildfire Smoke Exposure in California.
    Am J Respir Crit Care Med. 2022 Sep 14. doi: 10.1164/rccm.202203-0457.
    >> Share

    June 2022
  19. MARAIS BJ, Graham SM
    The Value of Chest Radiography in Tuberculosis Preventive Treatment (TPT) Screening in Children and Adolescents.
    Am J Respir Crit Care Med. 2022 Jun 2. doi: 10.1164/rccm.202205-1023.
    >> Share

    May 2022
  20. DOWDY DW
    Coughing is Not Required to Transmit Mycobacterium tuberculosis: Another Nail in the Coffin.
    Am J Respir Crit Care Med. 2022 May 25. doi: 10.1164/rccm.202204-0645.
    >> Share

  21. HUANG CC, Tan Q, Becerra MC, Calderon R, et al
    The Contribution of Chest Radiography to the Clinical Management of Children Exposed to Tuberculosis.
    Am J Respir Crit Care Med. 2022 May 24. doi: 10.1164/rccm.202202-0259.
    >> Share

  22. DINKELE R, Gessner S, McKerry A, Leonard B, et al
    Aerosolization of Mycobacterium tuberculosis by Tidal Breathing.
    Am J Respir Crit Care Med. 2022 May 18. doi: 10.1164/rccm.202110-2378.
    >> Share

  23. TOBIN MJ
    Fiftieth Anniversary of Uncovering the Tuskegee Syphilis Study: The Story and Timeless Lessons.
    Am J Respir Crit Care Med. 2022;205:1145-1158.
    >> Share

  24. DE JAGER V, Gupte N, Nunes S, Barnes GL, et al
    Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial.
    Am J Respir Crit Care Med. 2022;205:1228-1235.
    >> Share

  25. ESMAIL A, Oelofse S, Lombard C, Perumal R, et al
    An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study).
    Am J Respir Crit Care Med. 2022;205:1214-1227.
    >> Share

  26. OLIVIER KN, Prevots DR
    HALTing Nontuberculous Mycobacteria in Cystic Fibrosis Centers: Is There Something in the Water?
    Am J Respir Crit Care Med. 2022;205:982-983.
    >> Share

  27. GROSS JE, Caceres S, Poch K, Hasan NA, et al
    Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program.
    Am J Respir Crit Care Med. 2022;205:1064-1074.
    >> Share

    April 2022
  28. SHAKU MT, Bishai WR
    Mycobacterium tuberculosis: A Pathogen That Can Hold its Breath a Long Time.
    Am J Respir Crit Care Med. 2022 Apr 20. doi: 10.1164/rccm.202203-0432.
    >> Share

  29. BUCSAN AN, Veatch A, Singh DK, Akter S, et al
    Response to Hypoxia and the Ensuing Dysregulation of Inflammation Impacts Mycobacterium tuberculosis Pathogenicity.
    Am J Respir Crit Care Med. 2022 Apr 12. doi: 10.1164/rccm.202112-2747.
    >> Share

  30. PITTET LF, Fritschi N, Tebruegge M, Dutta B, et al
    Bacillus Calmette-Guerin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial.
    Am J Respir Crit Care Med. 2022;205:830-841.
    >> Share

    March 2022
  31. LANGE C, Barry Iii CE, Horsburgh CR Jr
    Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel.
    Am J Respir Crit Care Med. 2022 Mar 23. doi: 10.1164/rccm.202202-0393.
    >> Share

    February 2022
  32. COOKSON W, Moffatt M, Rapeport G, Quint J, et al
    A Pandemic Lesson for Global Lung Diseases: Exacerbations are Preventable.
    Am J Respir Crit Care Med. 2022 Feb 22. doi: 10.1164/rccm.202110-2389.
    >> Share

    January 2022
  33. SCHLUGER NW
    Of Mice and Men, Women, and Children: Using Animal Models to Inform Tuberculosis Clinical Trials of Novel Agents.
    Am J Respir Crit Care Med. 2022 Jan 31. doi: 10.1164/rccm.202112-2866.
    >> Share

  34. CHO HJ, Yu JH
    Quincke's Sign of Janeway Lesion in Infective Endocarditis.
    Am J Respir Crit Care Med. 2022 Jan 27. doi: 10.1164/rccm.202110-2362.
    >> Share

  35. O'DONNELL M, Mathema B
    Expanding the Tuberculosis Cascade of Care to Treat Undiagnosed and Subclinical Tuberculosis in High-Burden Settings.
    Am J Respir Crit Care Med. 2022;205:149-151.
    >> Share

    December 2021
  36. KAUSHIK A, Ammerman NC, Tasneen R, Lachau-Durand S, et al
    Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive Therapy.
    Am J Respir Crit Care Med. 2021 Dec 23. doi: 10.1164/rccm.202012-4541.
    >> Share

  37. FENNELLY KP, Martinez L, Mandalakas AM
    Tuberculosis: First in Flight.
    Am J Respir Crit Care Med. 2021 Dec 14. doi: 10.1164/rccm.202111-2513.
    >> Share

  38. SHIMIZU T, Watanabe S, Murata A, Kasahara K, et al
    Bronchial Cast Hiding Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2021 Dec 3. doi: 10.1164/rccm.202105-1306.
    >> Share

  39. SCHLUGER NW
    Using Isoniazid More Safely and More Effectively: The Time Is Now.
    Am J Respir Crit Care Med. 2021;204:1248-1250.
    >> Share

  40. WATERS V
    Two Steps Forward: Improving the Management of Cystic Fibrosis Pulmonary Exacerbations.
    Am J Respir Crit Care Med. 2021;204:1245-1247.
    >> Share

    November 2021
  41. BUNYASI EW, Middelkoop K, Koch A, Hoosen Z, et al
    Molecular Detection of Airborne Mycobacterium tuberculosis in South African High Schools.
    Am J Respir Crit Care Med. 2021 Nov 9. doi: 10.1164/rccm.202102-0405.
    >> Share

  42. ADJOBIMEY M, Behr MA, Menzies D
    Individualized Treatment Duration in Tuberculosis Treatment: Precision versus Simplicity.
    Am J Respir Crit Care Med. 2021;204:1013-1014.
    >> Share

    October 2021
  43. ATRE SR, Jagtap JD, Faqih MI, Dumbare YK, et al
    Tuberculosis Pathways to Care and Transmission of Multidrug-Resistance in India.
    Am J Respir Crit Care Med. 2021 Oct 27. doi: 10.1164/rccm.202012-4333.
    >> Share

  44. NOURSADEGHI M, Gupta RK
    New Insights into the Limitations of Host-Transcriptional Biomarkers of Tuberculosis.
    Am J Respir Crit Care Med. 2021 Oct 27. doi: 10.1164/rccm.202109-2146.
    >> Share

    September 2021
  45. LU S, Kolls JK
    Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model.
    Am J Respir Crit Care Med. 2021;204:626-627.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016